SCHEMBL29298633

SCHEMBL29298633

c1ccc(-c2ccc3cc(-c4nc(-c5ccccc5)nc(-c5cc(-c6ccccc6)c6oc7cc8ccccc8cc7c6c5)n4)ccc3c2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.38
KDM4E B2RXH2 4/20 0.38
MEN1 O00255 3/20 0.38
KMT2A Q03164 3/20 0.38
HSD17B10 Q99714 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
TP53 P04637 1/20 0.38
CYP1A2 P05177 1/20 0.38
PGR P06401 1/20 0.36
PIM1 P11309 1/20 0.34
CSNK2A2 P19784 1/20 0.34
CSNK2B P67870 1/20 0.34
PIM3 Q86V86 1/20 0.34
PIM2 Q9P1W9 1/20 0.34
ESR1 P03372 3/20 0.34
ESR2 Q92731 3/20 0.34
HSD17B1 P14061 1/20 0.34
HSD17B2 P37059 1/20 0.34
MAPT P10636 4/20 0.33
HPGD P15428 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29298634 1.00 ALDH1A1 (0.38) ALDH1A1KDM4EMEN1KMT2AHSD17B10
SCHEMBL29298620 0.98 ALDH1A1 (0.41) ALDH1A1KDM4EMEN1KMT2AHSD17B10
SCHEMBL24586855 0.98 KDM4E (0.38) ALDH1A1KDM4EMEN1KMT2AHSD17B10
SCHEMBL26416164 0.98 KDM4E (0.41) ALDH1A1KDM4EMEN1KMT2AHSD17B10
SCHEMBL24586853 0.96 HSD17B1 (0.36) ALDH1A1KDM4EMEN1KMT2AHSD17B10
SCHEMBL29298619 0.96 ALDH1A1 (0.42) ALDH1A1KDM4EMEN1KMT2AHSD17B10
SCHEMBL29298621 0.95 KDM4E (0.36) ALDH1A1KDM4EMEN1KMT2AHSD17B10
SCHEMBL24586564 0.95 KDM4E (0.41) ALDH1A1KDM4EMEN1KMT2AHSD17B10
SCHEMBL24585641 0.95 KDM4E (0.41) ALDH1A1KDM4EMEN1KMT2AHSD17B10
SCHEMBL24586852 0.95 ALDH1A1 (0.40) ALDH1A1KDM4EMEN1KMT2AHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240237514-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME AND COMPOSITION FOR ORGANIC MATERIAL LAYER LT MATERIALS CO., LTD. (KR) 2024-07-11 US disclosed
US-20240237514-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME AND COMPOSITION FOR ORGANIC MATERIAL LAYER LT MATERIALS CO., LTD. (KR) 2024-07-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240237514-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME AND COMPOSITION FOR ORGANIC MATERIAL LAYER CYP1A1, CYP1B1, CYP2E1 ALDH1A1 16/4885KDM4E 3419/4885MEN1 338/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.